Gail M. Clinton

2.7k total citations
45 papers, 2.3k citations indexed

About

Gail M. Clinton is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gail M. Clinton has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gail M. Clinton's work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (14 papers) and Virus-based gene therapy research (11 papers). Gail M. Clinton is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (14 papers) and Virus-based gene therapy research (11 papers). Gail M. Clinton collaborates with scholars based in United States, France and Spain. Gail M. Clinton's co-authors include Alice Huang, Edward J. Keenan, M F Lin, Joni K. Doherty, Elizabeth E. Ramsey, Wenhui Hua, Tracy A. Christianson, Boyce W. Burge, David D. Brandon and Miles J. Novy and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gail M. Clinton

43 papers receiving 2.1k citations

Peers

Gail M. Clinton
Jo Hilgers Netherlands
Paula Kavathas United States
Jon R. Wiener United States
Lucy F. Pemberton United States
I Hilgert Czechia
Tapan K. Bera United States
Michael I. Sherman United States
Daniel H. Wreschner Israel
N Kitamura Japan
Isabelle Rooney United States
Jo Hilgers Netherlands
Gail M. Clinton
Citations per year, relative to Gail M. Clinton Gail M. Clinton (= 1×) peers Jo Hilgers

Countries citing papers authored by Gail M. Clinton

Since Specialization
Citations

This map shows the geographic impact of Gail M. Clinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail M. Clinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail M. Clinton more than expected).

Fields of papers citing papers by Gail M. Clinton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail M. Clinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail M. Clinton. The network helps show where Gail M. Clinton may publish in the future.

Co-authorship network of co-authors of Gail M. Clinton

This figure shows the co-authorship network connecting the top 25 collaborators of Gail M. Clinton. A scholar is included among the top collaborators of Gail M. Clinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail M. Clinton. Gail M. Clinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Melanie, Gail M. Clinton, Nita J. Maihle, & Caroline N. Dealy. (2007). Requirement for ErbB2/ErbB signaling in developing cartilage and bone. Development Growth & Differentiation. 49(6). 503–513. 39 indexed citations
2.
Sáez, Rosana, Miguel Ángel Molina‐Vila, Elizabeth E. Ramsey, et al.. (2006). p95HER-2 Predicts Worse Outcome in Patients with HER-2-Positive Breast Cancer. Clinical Cancer Research. 12(2). 424–431. 161 indexed citations
3.
Staverosky, Julia A., Leslie L. Muldoon, Shuhua Guo, et al.. (2005). Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.. PubMed. 11(1). 335–40. 24 indexed citations
4.
Chatterji, Anju, Wendy F. Ochoa, Lara S. Shamieh, et al.. (2004). Chemical Conjugation of Heterologous Proteins on the Surface of Cowpea Mosaic Virus. Bioconjugate Chemistry. 15(4). 807–813. 91 indexed citations
5.
6.
Molina‐Vila, Miguel Ángel, Rosana Sáez, Elizabeth E. Ramsey, et al.. (2002). NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer.. PubMed. 8(2). 347–53. 177 indexed citations
7.
8.
9.
Doherty, Joni K., Chris T. Bond, Armando Jardim, John P. Adelman, & Gail M. Clinton. (1999). The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proceedings of the National Academy of Sciences. 96(19). 10869–10874. 107 indexed citations
10.
Doherty, Joni K., Chris T. Bond, Wenhui Hua, John P. Adelman, & Gail M. Clinton. (1999). An Alternative HER-2/neu Transcript of 8 kb Has an Extended 3′UTR and Displays Increased Stability in SKOV-3 Ovarian Carcinoma Cells. Gynecologic Oncology. 74(3). 408–415. 12 indexed citations
11.
Christianson, Tracy A., Joni K. Doherty, Ying-Ju Lin, et al.. (1998). NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.. PubMed. 58(22). 5123–9. 206 indexed citations
12.
Clinton, Gail M. & Wenhui Hua. (1997). Estrogen action in human ovarian cancer. Critical Reviews in Oncology/Hematology. 25(1). 1–9. 74 indexed citations
13.
Murray, Michael J., et al.. (1996). Endocrinology and paracrinology. Molecular Human Reproduction. 2(11). 823–828. 39 indexed citations
14.
Hua, Wenhui, Tracy A. Christianson, Christian Rougeot, Henri Rochefort, & Gail M. Clinton. (1995). SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. The Journal of Steroid Biochemistry and Molecular Biology. 55(3-4). 279–289. 73 indexed citations
15.
Brown, Nancy, Leigh A. Compton, & Gail M. Clinton. (1993). Antibodies against highly conserved sites in the epidermal growth factor receptor tyrosine kinase domain as probes for structure and function. Biochemistry. 32(17). 4659–4664. 4 indexed citations
16.
Brandon, David D., Cynthia L. Bethea, Miles J. Novy, et al.. (1993). Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. American Journal of Obstetrics and Gynecology. 169(1). 78–85. 164 indexed citations
17.
Christianson, Tracy A., et al.. (1992). Disulfide‐linked and noncovalent dimers of p185HER‐2 in human breast carcinoma cells. Journal of Cellular Biochemistry. 49(3). 290–295. 3 indexed citations
18.
Li, Shiwei, et al.. (1990). Insulin and epidermal growth factor stimulate phosphorylation of p185HER-2 in the breast carcinoma cell line, BT474. Molecular and Cellular Endocrinology. 69(2-3). 111–119. 15 indexed citations
19.
Li, Steven S.‐L., et al.. (1988). Cancer-Associated Lactate Dehydrogenase is a Tyrosylphosphorylated Form of Human LDH-A, Skeletal Muscle Isoenzyme. Cancer Investigation. 6(1). 93–101. 9 indexed citations
20.
Clinton, Gail M., et al.. (1978). The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell. 15(4). 1455–1462. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jo Hilgers Breakdown of academic impact, for papers by Paula Kavathas Breakdown of academic impact, for papers by Jon R. Wiener Breakdown of academic impact, for papers by Lucy F. Pemberton Breakdown of academic impact, for papers by I Hilgert Breakdown of academic impact, for papers by Tapan K. Bera Breakdown of academic impact, for papers by Michael I. Sherman Breakdown of academic impact, for papers by Daniel H. Wreschner Breakdown of academic impact, for papers by N Kitamura Breakdown of academic impact, for papers by Isabelle Rooney
Rankless by CCL
2026